SC Asks Uttarakhand Govt To Finalize Decision On Suspension Of 14 Patanjali Products In Two Weeks

New Delhi: The Supreme Court on Tuesday directed the Uttarakhand government to decide on the suspension of 14 products by yoga guru Ramdev’s Patanjali Ayurved, reported Live Law.

A bench of Justices Hima Kohli and Sandeep Mehta directed the Bharatiya Janata Party government in the state to decide on the matter within two weeks.

On April 29, the Uttarakhand State Licensing Authority for Ayurvedic and Unani Services told the court that the licences were suspended as Patanjali Ayurved had repeatedly violated the 1945 Drugs and Cosmetic Rules.

The 14 drugs that had been suspended were: Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh, Mukta Vati Extra Power, Lipidom, Bp Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold and Patanjali Drishti Eye Drop.

At the previous hearing on July 9, Patanjali Ayurved told a bench of Justices Hima Kohli and Sandeep Mehta that it had instructed 5,606 franchise stores to withdraw these products.

Media platforms were also instructed to withdraw advertisements for the 14 products, said the company. The court had asked Patanjali Ayurved to file an affidavit within two weeks, stating if social media intermediaries had withdrawn advertisements for the products.

At Tuesday’s hearing, the Indian Medical Association told the court that the 14 products were still available over the counter, even though Patanjali had earlier reportedly stopped their manufacturing.

Patanjali then told the court that the state government cancelled the suspension order on July 1 after considering the report of a committee constituted to look into the matter, reported Live Law.

Related Posts

Six fake doctors arrested in Hyderabad

Hyderabad Police apprehended six people who allegedly posed as doctors and treated people without holding any valid medical qualification. Five of them had earlier worked as compounders. Three of them…

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

According to the US FDA’s latest enforcement report, the recall was initiated after black spots were found on the tablets due to burnt excipient used for manufacturing. New Delhi: Sun…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Six fake doctors arrested in Hyderabad

Six fake doctors arrested in Hyderabad

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Meiji Seika to push new vaccine with SII in India

Meiji Seika to push new vaccine with SII in India

DGFT automates EO extension process to ease compliance for pharma exporters

DGFT automates EO extension process to ease compliance for pharma exporters